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Introduction
We present a patient with a splenic artery aneurysm
(SAA) managed by endovascular stenting.
Case Report
A 67-year-old female presented with a change in
bowel habit. CT pneumocolon identified no colonic
abnormality but did demonstrate a 7 cm SAA (Fig. 1).
There was no history of vascular disease or pancrea-
titis and no risk factors for atherosclerosis. One of her
two sisters had recently died following a ruptured
thoracic aortic aneurysm. The SAA was not palpable
and there was no other evidence of aneurysmal
disease.
Under local anaesthetic, a right common femoral
artery puncture was used for selective catheterisation
of the splenic artery. The diameter of, splenic artery on
each side of the aneurysm was 6.5 mm (Fig. 2). With a
stiff wire (Terumo) in the distal splenic artery a 10 Fr
flexi-sheath was advanced #across the aneurysm. An
8 mm by 7 cm Wallgrafte (Boston Scientific Vascular)
was deployed in the distal splenic artery with
subsequent angiography showing a proximal endo-
leak. Therefore a further 8 mm by 3 cm Wallgrafte
was deployed in the proximal splenic artery with final
angiography showing no endoleak (Fig. 3). The use of
two stents allowed flexibility to manage changes in
anatomy during the procedure.
Because of the potential risk of rupture vascular
surgical expertise was available during the procedure.
The patient made an uneventful recovery. Spiral CT
angiography at 24 h and 4 months demonstrated no
endoleak and a normally perfused spleen (Fig. 4).
Discussion
SAA have an estimated incidence of under 1%.1 They
comprise approximately 60% of splanchnic artery
aneurysms and are the third most common intra-
abdominal aneurysm.2 Females are four times more
likely to have SAA3 and they are most commonly
diagnosed during pregnancy. The strong female and
gestational predominance suggests that the aetiology
of the disease is different to other intra-abdominal
atherosclerotic aneurysms. In addition, patients with
liver disease (cirrhosis and portal hypertension) are
also at risk of SAA suggesting that an increased splenic
artery blood flow may be significant.
Most SAAs present incidentally either on plain X-
ray, during abdominal ultrasound or visceral angio-
graphy. The incidence of rupture appears low and in
Trastek’s series of 100 patients only four presented as
ruptures. Furthermore 34 of these cases were prospec-
tively observed for a mean of 6.4 years with only one
rupturing during this period.3 The incidental finding
of a small asymptomatic SAA seen as a calcified ring in
the left upper quadrant on plain X-ray is not
considered an indication for angiography. The two
absolute indications for treatment are rupture and
anticipated pregnancy.2
For asymptomatic non-gestational aneurysms, the
limited literature suggests that treatment should be
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considered for lesions greater than 2 to 3 cm in the
longest dimension.2,3 Surgical approaches vary from
resection and primary anastomosis to splenectomy
with or without distal pancreatectomy.
Until recently, the only treatment for SAA has been
open surgery, however as SAA are often saccular,
endovascular embolisation has gained popularity and
there are several reports of the success of this
technique.4 Unfortunately however, many patients
experience pain and fever following embolisation,
thought to be related to splenic ischaemia and the
technique is only effective in up to 85% of patients.4
The only other reported stenting of a SAA was with
the Jostent prosthesis (Jomed, Germany). In this case
Fig. 1. CT pneumocolon demonstrating 7 cm splenic artery
aneurysm.
Fig. 2. Selective visceral angiogram demonstrating 7 cm
splenic artery aneurysm with 6.5 mm ‘necks’.
Fig. 3. Two Wallgrafte prostheses deployed with occlusion
of endoleak.
Fig. 4. Spiral CT angiogram demonstrating well perfused
spleen, satisfactory position of grafts with no endoleak at 4
months.
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the broad based neck was occluded with a series of
three overlapping stents.5 The Wallgrafte endoprosth-
esis has been deployed successfully in iliac and
popliteal arteries and was considered suitable for use
in this patient. It allowed rapid occlusion of the
aneurysm sac and the patient required only 24 h
inpatient stay. To the best of our knowledge this is the
first successful use of a Wallgrafte endoprosthesis to
occlude a splanchnic artery aneurysm. This case
further illustrates the range of conditions amenable
to endovascular stenting as a result of the availability
of high quality, low profile interventional devices.
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